Antimicrobial Resistance — MCQs
The initial origin of new drug resistance genes in bacteria most commonly occurs due to:
The mechanism of direct transfer of free DNA involves _____
The molecular basis of penicillin resistance in *S. pneumoniae* is:
The most common mechanism of resistance to drugs in Staphylococcus is
What is the mechanism of resistance in MRSA?
All of the following are true about methicillin resistance in MRSA, except:
Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
All are false about tigecycline, except:-
Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?
A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?
Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Question 1: The initial origin of new drug resistance genes in bacteria most commonly occurs due to:
- A. Translation
- B. Mutation (Correct Answer)
- C. Conjugation
- D. Transduction
Explanation: ***Mutation*** - **Random genetic changes** in bacteria can alter drug targets or introduce drug-inactivating enzymes, leading to resistance. - **Spontaneous mutations** in the bacterial genome are the primary source of new resistance genes that did not previously exist in the bacterial population. - While mutations occur at low frequency, they are the fundamental mechanism by which novel resistance traits first arise. *Translation* - This is the process of synthesizing proteins from mRNA; it is a fundamental cellular process and not a cause of drug resistance. - Errors in translation are generally lethal to the cell and do not typically confer specific drug-resistant phenotypes. *Conjugation* - This is a mechanism for **horizontal gene transfer** where bacteria directly transfer genetic material, including resistance genes, via a pilus. - While conjugation is the **most important mechanism for spreading resistance** in clinical settings, it transfers pre-existing resistance genes rather than creating new ones. *Transduction* - This is another form of **horizontal gene transfer** involving bacteriophages (viruses) carrying bacterial genes, including resistance genes, between bacteria. - Similar to conjugation, transduction is a mechanism for the **transfer** of pre-existing resistance genes, not their original creation.
Question 2: The mechanism of direct transfer of free DNA involves _____
- A. Mutation
- B. Conjugation
- C. Transformation (Correct Answer)
- D. Transduction
Explanation: ***Transformation*** - **Transformation** is a process of horizontal gene transfer where bacteria take up **free DNA** from their environment. - This DNA can originate from dead bacterial cells and be integrated into the recipient bacterium's genome. *Mutation* - A **mutation** is a spontaneous change in the nucleotide sequence of an organism's genome. - It does not involve the transfer of DNA from one organism to another, but rather an alteration within an existing gene. *Conjugation* - **Conjugation** involves the direct transfer of genetic material between bacterial cells through physical contact via a **pilus**. - This mechanism typically transfers large pieces of DNA, often plasmids, not "free DNA" from the environment. *Transduction* - **Transduction** is the process by which DNA is transferred from one bacterium to another by a **bacteriophage** (a virus that infects bacteria). - This mechanism requires a viral vector to carry the genetic material, distinguishing it from the direct uptake of free DNA.
Question 3: The molecular basis of penicillin resistance in *S. pneumoniae* is:
- A. Alteration in cell membranes
- B. Alteration in the cell wall
- C. Alteration of penicillin-binding protein (Correct Answer)
- D. Production of beta-lactamase enzyme
Explanation: ***Alteration of penicillin-binding protein*** - The primary mechanism of **penicillin resistance in *Streptococcus pneumoniae*** involves modifications to its **penicillin-binding proteins (PBPs)**, which are the targets of penicillin. - These alterations reduce the affinity of PBPs for penicillin, allowing cell wall synthesis to continue even in the presence of the antibiotic. *Alteration in cell membranes* - Changes in cell membranes are not the primary mechanism of **penicillin resistance** in bacteria. - **Penicillins** primarily target the **bacterial cell wall**, not the cell membrane. *Alteration in the cell wall* - While penicillin resistance *involves* the cell wall, the direct "alteration in the cell wall" itself is not the molecular basis. - The key is the change in the **PBPs** located within or associated with the cell wall, not a general change in the cell wall structure. *Production of beta-lactamase enzyme* - **Beta-lactamase production** is a common mechanism of penicillin resistance in many bacteria (e.g., *Staphylococcus aureus*, *Haemophilus influenzae*), but it is **not the primary mechanism for penicillin resistance in *Streptococcus pneumoniae***. - *S. pneumoniae* primarily relies on **altered PBPs** to evade penicillin, rather than enzymatic degradation of the antibiotic.
Question 4: The most common mechanism of resistance to drugs in Staphylococcus is
- A. Transformation
- B. Transduction (Correct Answer)
- C. Episomes
- D. Conjugation
Explanation: ***Correct Option: Transduction*** - **Transduction** is the transfer of genetic material via **bacteriophages** and is the **most common mechanism** of horizontal gene transfer in *Staphylococcus aureus*. - Bacteriophages play a crucial role in disseminating **antibiotic resistance genes** in staphylococci, including genes for **methicillin resistance (mecA)**, **toxins**, and **beta-lactamase**. - Phage-mediated transfer is responsible for spreading many **virulence factors** and **resistance determinants** among staphylococcal populations. *Incorrect Option: Episomes* - **Episomes** are plasmids capable of integrating into the bacterial chromosome or existing autonomously. - While episomes can **carry resistance genes**, they are a **genetic element**, not a **mechanism of transfer**. - The question asks about the mechanism, not the vehicle carrying resistance genes. *Incorrect Option: Transformation* - **Transformation** involves uptake of **naked DNA** from the environment. - *Staphylococcus* species are **not naturally competent** for transformation under normal conditions. - This is not a significant mechanism of resistance acquisition in staphylococci. *Incorrect Option: Conjugation* - **Conjugation** requires direct cell-to-cell contact through a **conjugative pilus**. - While possible in *Staphylococcus*, it is **less common** compared to transduction. - Conjugation is more characteristic of **Gram-negative bacteria** and enterococci among Gram-positives.
Question 5: What is the mechanism of resistance in MRSA?
- A. PBP2a alteration (Correct Answer)
- B. Efflux pump activation
- C. Porins modification
- D. Beta-lactamase production
Explanation: ***PBP2a alteration*** - Methicillin-resistant Staphylococcus aureus (MRSA) acquires the **mecA gene**, which encodes for a modified penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for **beta-lactam antibiotics**, allowing the bacteria to synthesize its cell wall even in the presence of these drugs. *Efflux pump activation* - Efflux pumps are mechanisms used by bacteria to actively pump out various antibiotics from their cells, leading to resistance. - While efflux pumps contribute to resistance against other antibiotics, they are **not the primary mechanism** of methicillin resistance in MRSA. *Porins modification* - Porins are channels in the outer membrane of Gram-negative bacteria that allow the passage of hydrophilic molecules, including some antibiotics. - Modification of porins is a common resistance mechanism in **Gram-negative bacteria** but is not relevant to MRSA, which is Gram-positive. *Beta-lactamase production* - Beta-lactamases are enzymes that **hydrolyze the beta-lactam ring** of antibiotics like penicillin, rendering them inactive. - While many Staphylococcus aureus strains produce beta-lactamase (penicillinase) causing resistance to penicillins, MRSA's resistance to methicillin and other broader-spectrum beta-lactams is primarily due to **PBP2a alteration**, not just beta-lactamase production.
Question 6: All of the following are true about methicillin resistance in MRSA, except:
- A. Resistance is produced as a result of altered PBPs
- B. Resistance may be missed at incubation temperature of 37°C during susceptibility testing
- C. Resistance is primarily mediated/transmitted by plasmids (Correct Answer)
- D. Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics
Explanation: ***Resistance is primarily mediated/transmitted by plasmids*** - Methicillin resistance in MRSA is primarily mediated by the acquisition of the **mecA gene**, which encodes for an altered **penicillin-binding protein (PBP2a)**. - The mecA gene is located on a **staphylococcal chromosomal cassette mec (SCCmec)**, a mobile genetic element integrated into the bacterial chromosome, and **not transmitted via plasmids**. - This is the **false statement** and hence the correct answer to this "except" question. *Resistance is produced as a result of altered PBPs* - This statement is **true** as MRSA acquires the **mecA gene**, which encodes for an altered penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for beta-lactam antibiotics, allowing the bacterium to synthesize its cell wall even in the presence of these drugs. *Resistance may be missed at incubation temperature of 37°C during susceptibility testing* - This statement is **true**; **MRSA expression** can be heterogeneous and temperature-dependent. - Optimal detection of methicillin resistance often requires incubation at **lower temperatures (e.g., 30-35°C)** and/or the addition of salt (2-4% NaCl), as 37°C can sometimes mask the heterogeneous expression of resistance. *Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics* - This statement is **true**; the presence of **PBP2a** results in reduced binding of beta-lactam antibiotics to their target. - This leads to **increased MICs** for methicillin and other beta-lactam antibiotics, defining the resistance phenotype.
Question 7: Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
- A. Carbapenems (Correct Answer)
- B. Oxyimino-cephalosporins
- C. Penicillins
- D. Cephalosporins
Explanation: ***Carbapenems*** - **Extended-spectrum beta-lactamases (ESBLs)** typically do not hydrolyze **carbapenems**, making these antibiotics generally effective against most ESBL-producing bacteria. - The retention of activity against carbapenems is a key distinction between ESBLs and other beta-lactamases like **carbapenemases**. *Oxyimino-cephalosporins* - ESBLs are specifically named for their ability to hydrolyze and inactivate **oxyimino-cephalosporins**, such as **cefotaxime**, **ceftriaxone**, and **ceftazidime**. - This hydrolysis makes these vital third-generation cephalosporins ineffective for treating infections caused by ESBL-producing organisms. *Penicillins* - ESBLs can effectively hydrolyze and render many **penicillins** inactive, especially those lacking beta-lactamase inhibitors. - This broadens the resistance spectrum beyond just cephalosporins to include common penicillins. *Cephalosporins* - ESBLs primarily confer resistance to a wide range of **cephalosporins**, particularly the **first-, second-, and third-generation agents**. - This resistance is a major clinical challenge, necessitating the use of alternative antibiotic classes.
Question 8: All are false about tigecycline, except:-
- A. 90% pseudomonas strains are sensitive
- B. It is bactericidal drug
- C. It is a broad spectrum antimicrobial (Correct Answer)
- D. Dose reduction is required in renal failure
Explanation: ***It is a broad spectrum antimicrobial*** - **Tigecycline** is known for its wide spectrum of activity, effective against a variety of gram-positive, gram-negative, and anaerobic bacteria. - It is particularly useful in treating infections caused by **multidrug-resistant (MDR)** organisms, including MRSA and VRE. *90% pseudomonas strains are sensitive* - Tigecycline generally has **poor activity** against *Pseudomonas aeruginosa*, and its use is specifically cautioned against for such infections. - **Many *Pseudomonas* strains are intrinsically resistant** to tigecycline, making it an unreliable choice for treating these infections. *It is bactericidal drug* - Tigecycline is a **bacteriostatic** antibiotic, meaning it inhibits bacterial growth rather than directly killing bacteria. - It achieves its effect by binding to the **30S ribosomal subunit**, thereby blocking protein synthesis. *Dose reduction is required in renal failure* - **Tigecycline** is primarily eliminated via **biliary and fecal excretion**, with only a small portion excreted renally. - Therefore, **dose adjustments are generally not required** in patients with renal impairment, but caution is usually advised in severe hepatic impairment.
Question 9: Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?
- A. Due to plasmid exchange with other bacteria
- B. Due to absence of cell wall making beta-lactams ineffective
- C. Due to biofilm formation protecting from antibiotics
- D. Due to rapid mutation in the 23S rRNA gene (Correct Answer)
Explanation: ***Due to rapid mutation in the 23S rRNA gene*** [1] - *Mycoplasma genitalium* develops **resistance to macrolides**, a primary treatment, through **point mutations in the 23S rRNA gene** [1]. - These mutations alter the ribosomal binding site, preventing macrolide antibiotics from inhibiting **bacterial protein synthesis** [2]. *Due to plasmid exchange with other bacteria* - *Mycoplasma genitalium* **lacks a cell wall** and generally does not engage in significant plasmid exchange, which is a common mechanism for horizontal gene transfer and resistance acquisition in many other bacteria. - While other bacteria acquire resistance through plasmids, this mechanism is **not prominent** in *Mycoplasma genitalium*. *Due to absence of cell wall making beta-lactams ineffective* - The **absence of a cell wall** inherently makes beta-lactam antibiotics ineffective against *Mycoplasma genitalium*, as **beta-lactams target cell wall synthesis**. - However, this is a **natural resistance** and does not explain its higher rate of acquired antimicrobial resistance to other classes of antibiotics, such as macrolides. *Due to biofilm formation protecting from antibiotics* - While **biofilm formation can protect bacteria** from antibiotics, it is not the primary or most notable mechanism explaining the high rate of acquired resistance in *Mycoplasma genitalium*. - The major concern for *M. genitalium* resistance lies in **specific genetic mutations** affecting relevant antibiotic targets.
Question 10: A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?
- A. Patient preference
- B. Duration of therapy
- C. Local antimicrobial susceptibility patterns (Correct Answer)
- D. Route of administration
- E. Organism identification confirmation
Explanation: ***Local antimicrobial susceptibility patterns*** - Understanding local resistance patterns is crucial for selecting effective empiric therapy, especially with the high quinolone resistance (28%) mentioned. - **Empiric therapy** for suspected **gonorrhea** (suggested by intracellular gram-negative diplococci) must target common resistance mechanisms to ensure initial treatment success. *Patient preference* - While patient preferences can influence adherence, they do not guide the initial choice of antibiotic for a serious infection like gonorrhea, which requires an effective agent. - Clinical efficacy and public health considerations for preventing resistance take precedence over patient preference in selecting empiric therapy. *Duration of therapy* - The duration of therapy is determined *after* an effective antibiotic is chosen and is based on the specific infection and organism; it does not guide the initial selection of the drug itself. - Most gonorrhea treatments are single-dose, but this is a consequence of the chosen drug's efficacy rather than a guiding principle for selection. *Route of administration* - While practical for the patient, the route of administration (e.g., oral vs. intramuscular) is a secondary consideration after an effective agent is identified based on susceptibility. - Many empiric gonorrhea treatments include an intramuscular injection for single-dose efficacy, making route less of a primary guide for selection. *Organism identification confirmation* - Waiting for definitive organism identification and susceptibility testing would delay treatment and is inappropriate for symptomatic gonorrhea, which requires immediate empiric therapy. - The Gram stain already provides strong presumptive evidence, and empiric treatment must be initiated based on likely pathogens and local resistance patterns rather than waiting for culture confirmation.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free